Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling Journal Article


Authors: Traina, T. A.; Dugan, U.; Higgins, B.; Kolinsky, K.; Theodoulou, M.; Hudis, C. A.; Norton, L.
Article Title: Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling
Abstract: Background: To hasten and improve anticancer drug development, we created a novel approach to generating and analyzing preclinical dose-scheduling data so as to optimize benefit-to-toxicity ratios. Methods: We applied mathematical methods based upon Norton-Simon growth kinetic modeling to tumor-volume data from breast cancer xenografts treated with capecitabine (Xeloda®, Roche) at the conventional schedule of 14 days of treatment followed by a 7-day rest (14-7). Results: The model predicted that 7 days of treatment followed by a 7-day rest (7-7) would be superior. Subsequent preclinical studies demonstrated that this biweekly capecitabine schedule allowed for safe delivery of higher daily doses, improved tumor response, and prolonged animal survival. Conclusions: We demonstrated that the application of Norton-Simon modeling to the design and analysis of preclinical data predicts an improved capecitabine dosing schedule in xenograft models. This method warrants further investigation and application in clinical drug development. © 2010 - IOS Press and the authors. All rights reserved.
Keywords: cancer chemotherapy; cancer survival; controlled study; survival rate; overall survival; drug safety; nonhuman; drug approval; capecitabine; mouse; breast cancer; tumor volume; animal experiment; animal model; antineoplastic activity; mathematical model; drug dose escalation; drug research; xenograft; optimal drug dose; drug dose regimen; mathematical computing; process optimization; chemotherapy schedule; norton-simon; xeloda®; chemical reaction kinetics
Journal Title: Breast Disease
Volume: 31
Issue: 1
ISSN: 0888-6008
Publisher: IOS Press  
Date Published: 2010-01-01
Start Page: 7
End Page: 18
Language: English
DOI: 10.3233/bd-2009-0290
PROVIDER: scopus
PMCID: PMC3228251
PUBMED: 20519801
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "CODEN: BRDIE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Larry Norton
    758 Norton
  3. Tiffany A Traina
    250 Traina